Golden State Orthopedics & Spine

The management of mangled extremities has long produced contention among the orthopaedic surgery community due to injury complexity and difficulty predicting postoperative outcomes for limb reconstruction and amputation. This review discusses a series of reliable prognostic indicators and socioeconomic factors that can drastically alter the feasibility and burden of various treatments for mangled lower extremity patients and treating surgeons. This review emphasizes an integrated, multidisciplinary approach to mangled extremity management, allowing for efficient utilization of resources and prompt stabilization and fixation for patients. The guidelines detailed in thie review may expedite clinical decision-making and improve outcomes for future patients.

The management of mangled extremities has long produced contention among the orthopedic surgery community due to the complexity of injuries and difficulty predicting postoperative outcomes for limb reconstruction and amputation. This review discusses reliable prognostic indicators as well as socioeconomic factors that can drastically alter the feasibility and burden of various treatments for mangled lower extremity patients and treating surgeons. This review emphasizes an integrated, multidisciplinary approach to mangled extremity management, allowing for efficient utilization of resources and prompt stabilization and fixation for patients. The guidelines detailed in this review may expedite clinical decision-making and improve outcomes for future patients.

This study aimed to assess the trends in Medicare reimbursement for common hip arthroplasty procedures from 2006 to 2024.

This study analyzed data from the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule from 2006 to 2024 to identify payment trends for the most common orthopaedic procedures related to hip arthroplasty. The study calculated Medicare reimbursement by multiplying relative value units by a Centers for Medicare & Medicaid Services-determined conversion factor and adjusted reimbursement rates for inflation to 2024 U.S. dollars using the Consumer Price Index inflation calculator from the U.S. Department of Labor. Projections for future trends were derived from mean values from 2020 to 2024, with data visualizations created in Microsoft Excel.

From 2006 to 2024, total reimbursements for medical procedures dropped by 0.1%, while the Consumer Price Index increased by 55%. This caused the average reimbursement to fall by 35.5%. The biggest decrease was in primary total hip arthroplasty reimbursement, which fell by 40.7%. Additionally, the unadjusted work reimbursement rate for all procedures went down by 6.1%, resulting in a substantial inflation-adjusted decrease of 39.4%. If these trends continue, projections for 2029 suggest an additional projected decline in surgeon reimbursement of 33 to 42%, and work reimbursements could drop by 40 to 50%.

From 2006 to 2024, inflation-adjusted Medicare reimbursement for hip arthroplasty has dropped markedly, challenging orthopaedic practices' sustainability. This may lead health care providers to see more patients, risking burnout and affecting patient outcomes. Compensation for orthopaedic surgeons should reflect the patient value added. However, this study demonstrates a progressive decrease in physician reimbursement, which could lead to an unneeded financial burden on orthopaedic practices. The focus should be on advocating for better reimbursement policies to maintain practice integrity rather than just increasing patient volume.